Lung Cancer Clinical Trials in Salt Lake City

Showing 281-286 of 286 trials

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

NCT00465725

Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.

Bladder CancerBreast CancerColorectal Cancer+6 more

Poniard Pharmaceuticals18 participantsStarted Apr 2007

Atlanta, Georgia, United States • Las Vegas, Nevada, United States • Tacoma, Washington, United States

UNKNOWNPHASE1/PHASE2362 miles

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00082472

This study is intended to show whether inhaled chemotherapy can be added to a standard IV chemotherapy regime, to investigate the additional toxicities and to show initial evidence of efficacy of the combination.

NSCLC

Zivena30 participantsStarted Jan 2004

New Haven, Connecticut, United States • Las Vegas, Nevada, United States • Las Vegas, Nevada, United States +3 more locations

COMPLETEDPHASE2485 miles

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

NCT00129844

The purpose of this study is to determine the effect of MGd in non-small-cell lung cancer (NSCLC) when given alone, and to evaluate the difference between two dosing regimens.

AdenocarcinomaNon-Small-Cell Lung CarcinomaLung Neoplasms

Pharmacyclics LLC.108 participantsStarted Sep 2005

Fountain Valley, California, United States • Los Angeles, California, United States • Palm Springs, California, United States +13 more locations

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

Lung Cancer Trials in Other Cities

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Other Conditions in Salt Lake City